Herriot Tabuteau
2020
In 2020, Herriot Tabuteau earned a total compensation of $7.3M as Chief Executive Officer, President and Chairman of the Board at Axsome Therapeutics, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $448,500 |
|---|---|
| Option Awards | $4,665,329 |
| Salary | $575,000 |
| Stock Awards | $1,615,860 |
| Total | $7,304,690 |
Tabuteau received $4.7M in option awards, accounting for 64% of the total pay in 2020.
Tabuteau also received $448.5K in non-equity incentive plan, $575K in salary and $1.6M in stock awards.
Rankings
In 2020, Herriot Tabuteau's compensation ranked 1,312th out of 13,090 executives tracked by ExecPay. In other words, Tabuteau earned more than 90.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,312 out of 13,090 | 90th |
Division Manufacturing | 471 out of 5,618 | 92nd |
Major group Chemicals And Allied Products | 165 out of 2,251 | 93rd |
Industry group Drugs | 142 out of 1,951 | 93rd |
Industry Pharmaceutical Preparations | 103 out of 1,456 | 93rd |
Pay ratio
| Herriot Tabuteau's Pay | $7,304,690 |
|---|---|
| Median Employee's Pay | $299,771 |
| Pay Ratio | 24to 1 |
In 2020, the annual total compensation of Herriot Tabuteau was $7,304,690.
The annual total compensation of the median employee at Axsome Therapeutics was $299,771.
The ratio of Herriot Tabuteau's pay to the pay of median employee was therefore 24 to one.
Source: SEC filing on April 23, 2021.
Tabuteau's colleagues
We found three more compensation records of executives who worked with Herriot Tabuteau at Axsome Therapeutics in 2020.